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Augmented aldosterone and insulin responses to potassium infusion in
dogs with renal failure. The present study examines acute potas-
sium—induced insulin and aldosterone responses in renal failure, and the
role of chronic dietary potassium intake in modifying these acute
responses. Plasma aldosterone (PA) and insulin (IRI) responses to acute
KC1 infusion were examined in control and remnant kidney dogs on two
potassium intakes. Dogs (N = 8) received the KC1 infusions after 10
days of a 60, and then 10 days of a 200, mEq daily potassium intake
during control and alter surgical—induced renal failure (CRF), A one
hour intravenous infusion of KCI (2 mEq KClIkg/hr) in dextrose and
water was performed with blood samples for PA, IRI, creatinine and
electrolytes, and urine for electrolytes and creatinine at 20 minute
intervals one hour preceding, during, and after the infusion. Pre-
infusion PA was higher (P < 0.05) in controls and CRF dogs on 200 mEq
potassium intake compared to 60 mEq potassium intake. The peak
incremental responses of PA to KC1 infusion were increased (P < 0.01)
in CRF compared to controls on 60 mEq (PA 36 4.2 vs. 26 3.0ngldl)
and 200 mEq ( PA 49 5.6 vs. 37 2.8 ng/dl) potassium intakes.
Differences in incremental PA responses in CRF were not due to altered
aldosterone metabolic clearance rates, changes in renin, or ACTH
activity. Pre-infusion IRI was higher (P < 0.05) in CRF than control
dogs on both potassium diets. The peak incremental IRI responses to
KCI infusion were also increased (P < 0.01) in CRF on the 200 mEq
potassium diet (IRI 140 16 jsU/ml) compared to controls (39 3
sU/ml). Responses were also greater (P < 0.05) in CRF than control
dogs on the 60 mEq potassium intake (IRI 27 3 jsU/ml vs. 20 1.4
jsU/ml). Plasma potassium increased significantly during KC1 infusion,
but potassium increments showed no significant differences between
the four study groups. The percent fractional excretion of potassium
was augmented in CRF on both potassium diets during basal and
infusion periods, but UKV was markedly blunted in CRF in response to
the KC1 infusion. Analysis of potassium distribution revealed a marked
increase in potassium transfer from the extracellular to the intracellular
compartment of CRF dogs. Thus, the sensitivity of adrenal PA and
pancreatic IRI secretion to acute potassium loading is augmented in
renal failure. The close temporal relationship between the high levels of
PA and IRI and enhanced intracellular uptake of potassium indicate
they could participate in the extrarenal disposal of potassium in renal
failure. It could be postulated that the increased tissue uptake of
potassium in CRF also occurs in the adrenal gland and pancreas and
further activates hormonal secretion.
Several mechanisms participate to maintain potassium
homeostasis in response to potassium challenge in chronic renal
insufficiency. One mechanism producing potassium adaptation
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in renal insufficiency involves enhanced potassium excretion in
the remaining functional nephrons [1]. The site of this action in
uremia appears to be in the cortical collecting tubule as de-
scribed in rabbits [21, and its mechanism has been noted to be
independent of mineralocorticoid action [1, 21. The participa-
tion of non-renal factors to maintain potassium balance in these
circumstances is less clear. Previous observations in man and
animals suggest that aldosterone levels are either within normal
range in stable, chronic renal insufficiency [3, 4] or may
demonstrate an increase in a linear relationship to increasing
potassium [5, 6]. Insulin levels can be elevated in renal insuffi-
ciency and could contribute to extrarenal potassium disposal.
As the potassium ion stimulates secretion of both aldosterone
and insulin, a feedback servoregulatory system may exist to
maintain internal and external potassium balance [7]. How this
proposed hormonal regulatory system operates to minimize
hyperkalemia under maximal challenge, including acute potas-
sium loading, combined with high dietary potassium intake is
not clarified in renal failure.
We examined the acute responses of plasma aldosterone and
insulin to intravenous potassium loading in remnant kidney
dogs, and particularly the effect of high potassium intake (200
mEq potassium) on these hormonal responses. Potassium ex-
cretion and distribution after acute potassium loading were also
examined in the remnant kidney model during low and high
external potassium balance.
Methods
Eight adult, female mongrel dogs were studied with approval
of the Animal Studies Subcommittee, VA Medical Center,
Sepulveda, California, USA. Renal mass of one kidney was
reduced by approximately 75% by ligating the majority of the
second and third order branches of the ipsilateral renal artery
[1]. After two weeks, the intact kidney was removed with only
the remnant kidney continuing to function. Food and electro-
lytes were administered by gastric tube in two equal feedings
throughout the study period. The diet consisted of a synthetic
mixture which was sodium free and contained 18% casein, 72%
sucrose, and 5% butter fat (Nutritional Biochemicals, Cleve-
land, Ohio, USA). Animals received 125 g in each feeding,
providing approximately 120 kcal per day. Potassium was
added to the meal as KC1 to provide a constant 60 mEq or 200
mEq daily intake depending on the study. The intake of sodium
chloride was constant at 80 mEq per day added to the feedings
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Table 1, Pre-study data for control and renal failure dogs
throughout the study. Animals were studied (acute KC1 infu-
sions) on both the 60 and 200 mEq potassium intakes before
(control) and after surgery (renal failure), allowing six to 10
days to attain metabolic balance on each diet. The sequence of
dietary potassium intake was randomized.
At the end of each dietary potassium intake period the dogs
received an acute potassium infusion. Thus, each dog had two
infusions before and two infusions after surgery on each of the
potassium diets. The dogs were accustomed to the study
environment by daily handling and frequent attachments to the
study table with a support sling. They were weighed before
each study. All experiments were performed with the animals
awake and standing quietly in the supporting sling. Two hours
before the study they received their morning feeding and one
hour before the infusion, they received a priming solution of
creatinine intravenously and a 500 ml water load by gastric
tube. A catheter was inserted in the urethra, facilitated by a
previously performed episiotomy in each dog.
The dogs received a constant intravenous infusion of KCI in
5% dextrose and water to deliver 2 mEq KC1 per kg body
weight for one hour. The solution also contained creatinine in a
concentration calculated to determine its clearance rate. Sam-
pie collection periods for blood and urine consisted of three
collections before, three during and three after the infusion, all
at 20 minute intervals. Blood samples were collected for plasma
aldosterone, insulin, creatinine, sodium and potassium. Addi-
tionally, samples for plasma renin activity, blood glucose, and
cortisol were obtained before and at the end of the KC1
infusion. Approximately 4 ml of blood was removed at each
drawing and was replaced by an equivalent volume of normal
saline. Urine was collected during each 20 minute study period
for measurement of volume, creatinine, sodium and potassium.
In five of the eight dogs, a metabolic clearance rate for
aldosterone was performed by constant infusion of 3H-aldoste-
rone on the last day of the 200 mEq potassium diet before and
after surgery. The timing allowed a two week period to exclude
any residual tritiated aldosterone in the blood that could inter-
fere with the radioimmmunoassay procedures.
Plasma aldosterone was measured by the RIA method of
Mayes et al [81. The sensitivity of this assay is 4 pg/ml and the
intra-assay coefficient of variation is 7%. Plasma insulin was
measured in triplicate on two occasions by RIA [9]. Plasma
renin activity was measured by the method of Haber et al [10].
Plasma cortisol was measured by a direct RIA procedure
developed at Endocrine Sciences Laboratory, Tarzana, Califor-
nia, USA. Sodium, potassium, and creatinine in plasma and
urine and blood glucose were measured by autoanalyzer. The
metabolic clearance rate of aldosterone was determined by a
modification of the method of Tait et all!!]. Clearance was
calculated by the relationship of the steady—state concentration
of 3H-aldosterone analyzed in three successive samples at 10
minute intervals after a 120 minute equilibration of a constant
dose infusion of 3H-aldosterone.
Results between different dietary groups before and after
surgery were compared by means of unpaired (-tests. Results
during infusion studies in each group were compared to baseline
using Dunnett's method for multiple comparisons [12]. Results
are expressed as mean SEM.
Results
Preinfusion measurements for the four study groups are
shown in Table 1. Glomular filtration rate was significantly
reduced in remnant kidney dogs compared to presurgical val-
ues. Values for plasma sodium were lower, but not significantly
different in the renal failure groups compared to control. The 24
hour urinary sodium excretion collected after 10 days of the 80
mEq sodium intake indicated that the dogs were studied in a
comparable range of sodium balance. Control and renal failure
dogs on high potassium intake showed no significant difference
in sodium excretion compared to their values during the lower
potassium intake. Pre-infusion plasma potassium values were
highest in the renal failure, high—potassium intake group, but
differences were not significant. Urinary potassium excretion
was significantly higher in control and renal failure dogs on 200
mEq compared to 60 mEq KC1 diets. During the renal failure
period there was a reduction in body weight in some dogs, but
mean body weight changes in control compared to renal failure
were not significant. Mean plasma bicarbonate values in con-
trols on 60 mEq KC1 (21.3 1.8 mEq/liter) and 200 mEq KCI
(21.8 1.4 mEqiliter) were significantly (P < 0.05) higher than
values in renal failure on the low (18.3 1.2 mEqlliter) and high
(19 1.0 mEq/liter) KCI diets. Differences in plasma bicarbon-
Plasma
Plasmaa Urinary Plasma' Urinary Plasmaa Plasmaa renin
GFR sodium sodium potassium potassium Weight aldosterone insulin activity
mi/mm mEqiliter mEq/24° mEqiliter mEq/24° kg ng/dl pU/ml ng/ml/hr
Control
60 mEq KC1
Diet (N = 8)
200 mEq KC 1
Diet (N — 8)
Renal failure
60 mEqKCl
Diet (N = 7)
200 mEq KC1
Diet (N
—8)
55 7 141 + 1 68 8 4.35 + 0.1 54 8 16.2 + 2 13 2 14 2 2.13 0.6
49 + 6 140 2 74 9 4.41 0.08 186 22b 18.3 2 21 2,3b 43 5b 1.64 0.6
11±3° 138±2 78±8 4.34±0.14 46±8 15.1±2 16±3 53±6c 1.82±0.8
13 3C 139 -- 1 86 10 4.54 + 0.10 178 26 16.8 3 43 5,5° 112 16c,d 1,72 0.5
a Individual values derived from the average of 3 samples obtained at 20 mm intervals before the KCI infusion
b P < 0.05 compared to control, 60 mEq potassium
P < 0.01 compared to control
d P < 0.05 compared to renal failure, 60 mEq potassium
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ate were not significant between the two dietary study groups in
control or renal failure dogs.
Aldosterone
Pre-infusion plasma aldosterone concentrations during con-
trol and chronic renal failure were similar on the 60 mEq
potassium diet (Table 1). In controls and chronic renal failure
on 200 mEq potassium diet, plasma aldosterone was signifi-
cantly (P < 0.05) elevated over the 60 mEq intake (Table 1).
There were significant increases in plasma aldosterone over
preinfusion in response to KC1 infusion in the four study
groups. In the control groups, peak plasma aldosterone re-
sponses to KC1 infusion were greater (P < 0.05) on 200 (55
6.8 ngldl) than on 60 (39.3 4.2 ngldl) mEq potassium intakes,
as were their incremental responses as shown in Fig. 1. Renal
failure dogs demonstrated additional enhancement of peak
plasma aldosterone responses to KC1 infusion compared to
controls on both the 60 mEq (58 8 ngfdl, P < 0.05) and 200
mEq (93 12.2 ngldl) potassium intakes, and also differences in
incremental responses (P < 0.01, Fig. 1). Among the renal
failure dogs, plasma aldosterone responses to KC1 infusion
were greater (P < 0.05) on the 200 than 60 mEq potassium diets.
Mean metabolic clearance rate of aldosterone performed in
five dogs on 200 mEq potassium intake was lower (700 120
mi/mm) in renal failure dogs than controls (810 92 mI/mm);
these differences were not significant even when corrected for
body weight. Mean PRA levels (Table 1) were not significantly
different between the four study groups. PRA levels at the end
of the KCI infusion were not changed from pre-infusion values.
Plasma cortisol values sampled in the pre-infusion period
ranged from 12 to 24 p.g/dl, but mean values did not differ
between the four study groups. A sham one—hour infusion of
5% dextrose in water without KC1 was performed in three
remnant kidney dogs on 200 mEq potassium intake. Increments
in plasma aldosterone at 20 minutes (3.2 0.6 ng/dl) and 40
minutes (4.1 0.5 ngldl) were not significantly different from
baseline (3.8 5.1 ng/dl).
Insulin
Pre-infusion plasma insulin concentrations were greater (P <
0.05) in control dogs on 200 mEq compared to 60 mEq potas-
sium diet (Table 1). Pre-infusion insulin was also elevated in
renal failure dogs on both potassium diets, being highest on the
200 mEq potassium intake (Table 1). There were significant
increases in insulin over pre-infusion levels in response to KC1
infusion. Peak insulin responses to KC1 infusion on the 60 mEq
potassium diet were significantly (P < 0.05) greater in renal
failure dogs (81 8.9 iiUlml) compared to controls (34 5.2
U/ml) as were the incremental responses shown in Fig. 2A.
Peak insulin responses to KC1 infusion were most strikingly
increased in chronic renal failure during the 200 mEq potassium
intake (254 34 jsU/ml), as were the incremental increases
shown in Fig. 2B. Control dogs on the 200 mEq potassium
intake also had greater (P < 0.05) insulin peak response (81
11 UIml) and incremental responses compared to controls on
60 mEq potassium intake (Fig. 2).
The plasma insulin responses were accompanied by moderate
reductions in blood glucose. Pre-infusion mean glucose for all
groups (82 10 mgldl) decreased significantly (P < 0.05) in the
post-infusion period (68 8 mgldl). No evidence of hypogly-
Time, mm
Fig. 1. Incremental changes in plasma aldosterone in response to a 60
minute KCI infusion in control and renal failure dogs (N = 8) studied on
60 mEq (A) and 200 mEq (B) potassium diets. Mean SEM. Symbols:
*p < 0.05 and < 0.01 refer to differences in control versus renal
failure.
cemia was noted during the KC1 infusion studies, and blood
sugar fell below 50 mgldl in only two dogs. All animals were
receiving dextrose with the KC1 infusion. Additionally, three
renal failure dogs on the 200 mEq potassium intake received a
sham one—hour infusion of 5% dextrose in water without KC1 at
an equivalent infusion rate. Mean incremental insulin levels at
20 minutes (18 3.2 tU/ml) and 40 minutes (29 5.6 pU/mi)
of dextrose infusion were elevated over baseline (72 12
pU/mI), but were much lower than levels during KC1 infusion.
Plasma potassium
Figure 3 depicts plasma potassium responses to KC1 infusion
under the four study conditions. Mean KC1 infusion rate for all
groups was 36.6 3.4 mEq per hour, and individual group
values are shown in Table 2. Each group demonstrated signif-
A
50
KCI infusion 1
40
30
20 Control
=1
0
B
50
40
30
Renal
failure
Control
20
10
0
0 20 40 60 80 100 120
886 Tuck et a!
[ Basal IfliEl infusion Post-infusion
significantly increased in control dogs being greatest in the
control group on 200 mEq potassium intake (Fig. 4). There was
a markedly blunted kaliuresis during potassium loading in renal
failure dogs and dietary potassium intake had very little effect
on UKY which was not different between the 60 and 200 mEq
potassium intake group (Fig. 4). Post-infusion UKV declined
less rapidly in renal failure dogs compared to controls. The
fractional excretion of potassium in control dogs was signifi-
cantly greater (P C 0.05) on the 200 mEq potassium diet only
during the KC1 infusion period (Fig. 5). In renal failure dogs
fractional excretion of potassium was increased (P C 0.01) over
controls during basal, infusion, and post-infusion periods (Fig.
5). There were not, however, any major differences in fractional
excretion of potassium between the two dietary groups in renal
failure dogs.
Potassium distribution
icant peak and incremental increases in plasma potassium over
basal levels during KC1 infusion (Fig. 3). Incremental responses
were not significantly different between the study groups,
e?cept in the 60 mEq renal failure group (Table 2). The rate of
reduction of plasma potassium in the post-infusion period was
slightly delayed in the renal failure group on high potassium
intake (Fig. 3). This delay could be explained by a residual
effect of the pre-study oral ingestion of 100 mEq KCI as part of
their morning feeding.
Potassium excretion
The mean urinary excretion rate of potassium as a function of
time (UKV) for the four study groups is depicted in Fig. 4.
Preinfusion UKV was highest in controls on 200 mEq and
lowest in controls on 60 mEq potassium. There was no differ-
ence in basal mean UKY between renal failure dogs on the two
potassium intakes. The kaliuretic response to KCI infusion was
Table 2 depicts the calculated distribution of the infused
potassium load in the four study groups. Calculations for
potassium distribution were performed on values taken at 60
minutes of the KC1 infusion, a time that represented maximal
increments in plasma potassium for most dogs. Extracellular
potassium distribution was calculated from the incremental
change in plasma potassium times 3.2 liters of ECF. Intracel-
lular potassium distribution was calculated as the difference
between extracellular levels and the amount retained during this
time period. All study groups received equivalent potassium
loads based on body weight. The renal failure dogs on 60 mEq
potassium who had lower body weights and received the lowest
infusion also displayed the least increment in serum potassium
and the lowest potassium content in the extracellular space
(Table 2). Accompanying the blunted kaliuresis was a signifi-
cant increase in intracellular potassium uptake in response to
potassium loading in renal failure dogs (Table 2). As the
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Fig. 3. Changes in mean plasma potassium before, during, and follow-
ing a 60 minute KCI infusion in control and renal failure dogs (N = 8)
studied on 60 mEq and 200 mEq potassium diets. Control 60 (O---O)
and 200 (A---A) mEq potassium; renal failure 60 (•---S) and 200
(A---A) mEq potassium intakes.
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Fig. 2. Incremental changes in plasma insulio response to a 60 minute
KC1 infusion in control and renal fbilure dogs (N = 8) studied on 60
mEq (A) and 200 mEq (B) potassium diets. Mean 5EM. Symbols: °P
< 0.05 and ** < 0.01 refers to differences in control versus renal
failure.
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Table 2. Distribution of infused KC 1 in control and renal failure dogs (mean + SEM)
% transfer
Increment Extracellular Intracellular of infused
Total KC1 in serum potassium potassium KC1 to
infused potassium UkV distributiona distribution extrarenal
mEq mEq/liler p.Eqlmin mEq mEq tissues
Control
60 mEq KC1 32.4 3.0 2.1 0.34 11.8 2.8 6.7 0.14 13.9 0.24 42.6
Diet (N = 8)
200 mEq KC1 36.6 3.4 1.6 0.18 14.4 3.0 5.8 0.18 16.4 0.64 44.8
Diet (N = 8)
Renal failure
60 mEq KC1 30,2b 3.1 0.9 0.l4t 4.1 l.4C 3.2 010b 22.9 0.44c 75.8'
Diet (N = 7)
200 mEg KC1 33.6 2.9 1.7 0.26 4.8 1.2c 6.1 0.18 22,7 0.38C 67.6C
Diet (N = 8)
a Calculated based on assumed extracellular space of 3.2 liter
' P < 0.05 compared to all other study groups
P < 0.01 compared to control groups
percentage transfer of the potassium load to extrarenal tissue
was not significantly different on the two potassium diets, there
appeared to be little effect of external potassium balance on this
function in control and renal failure animals.
Discussion
The present study examined insulin and aldosterone re-
sponses to acute potassium loading in remnant kidney dogs with
renal failure. The results indicate enhancement of adrenal zona
glomerulosa cell—sensitivity for aldosterone release and pancre-
atic beta—cell sensitivity for insulin release in response to acute
potassium challenge in dogs with renal failure. As plasma
potassium levels were not significantly different, these results
imply that adrenal cortical cells and pancreatic beta cells
become more responsive in renal failure to equivalent changes
in plasma potassium. Our results also indicate that external
potassium balance as assessed by dietary potassium intake has
significant effects on preinfusion aldosterone and insulin levels
in control and renal failure dogs. Pre-infusion aldosterone levels
were increased threefold and insulin twofold in renal failure
dogs on 200 mEq KCI diet compared to 60 mEq diet. This
well—established effect of high dietary potassium on insulin and
aldosterone levels was also seen in control dogs. Pre-infusion
and infusion plasma potassium levels were not different under
the four study conditions, implying that several adaptive pro-
cesses come into play during chronic high—level ingestion of
potassium.
Potassium is a potent, direct stimulator of aldosterone secre-
tion. Acute and chronic administration of potassium in animals
and man increases the secretion of aldosterone [13—171. Small
changes in potassium concentration in the order of 0.2 to 0.3
mEq per liter can produce significant changes in aldosterone
secretion [14, 15]. Some studies in experimental and human
renal failure have not supported a major role for aldosterone in
the adaptive responses against hyperkalemia [18—201. Others [5,
21] have found a close relationship between serum potassium
and aldosterone increments in renal insufficiency. One report of
intravenous potassium infusion in anuric subjects described
brisk aldosterone responses but questioned the physiologic
significance of these responses in potassium disposal [22].
1 2 3 4 5 6 7 8 9
Basal KCI infusion Post-infusion
Fig. 4. Timed urinary potassium excretion rates (UKV) before, during,
and after KC1 infusion in control dogs (N = 8), studied on 60 (O---O)
and 200 (---) mEq potassium diets and renal failure dogs (N = 7), on
60 (•---•) and 200 (A---A) mEq potassium diets.
Potassium itself may also increase the action of aldosterone, as
rats fed a high potassium diet demonstrated enhanced renal
sensitivity to the action of aldosterone [23]. Our results indicate
that an additional component to potassium control in renal
failure is an enhanced adrenal sensitivity for potassium—induced
aldosterone release and that higher potassium dietary balance
further augments these acute aldosterone responses. In normal
animals increased aldosterone secretion is observed in response
to angiotensin II and ACTH after dietary potassium loading
[24—261. Our potassium distribution studies showing enhanced
tissue uptake in renal failure could also involve the adrenal
gland; an increased adrenal uptake of potassium could contrib-
ute to the augmented aldosterone responses that occurred,
despite equivalent potassium intakes. Bourgoinie et al [27]
evaluated the effect of acute oral potassium loading on aldos-
terone in the dog remnant kidney model on a low (15 mEq)
potassium intake. After a 50 mEq KC1 oral challenge they noted
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Fig. S. Fractional excretion of potassium (%) before, during, and after
KC1 infusion in control and renalfailure dogs (N 7,) studied on 60 and
200 mEq potassium diets, mean SEM.
a significant, but identical, increase in serum aldosterone in
normal and remnant dogs over one to two hours, but a more
prolonged three to five hour aldosterone response in the rem-
nant dogs. Their results differed from our study in that remnant
dogs had a greater elevation in serum potassium to oral KCI
loading than controls. These disparities in results of the two
studies may be explained by differences in dietary potassium
balance and routes of acute KCI loading. Their studies do point
out an important aspect to interpretation of our study results.
As the dogs received their morning feeding two hours before the
infusion, some residual effect of the different oral KC1 loads
may influence the results of the KCI infusion. As they showed
an effect on aldosterone up to five hours, these responses would
be further enhanced in the 200 mEq KCI diet groups.
The importance of the renin—angiotensin system in potas-
sium—induced stimulation of aldosterone release has been elu-
cidated. Pratt [28] observed that administration of an angioten-
sin converting—enzyme inhibitor in dogs blocked the effect of
intravenous KCI on aldosterone secretion. The pre-infusion
levels of renin in our study groups were not significantly
different. This would exclude major differences in the renin—
angiotensin system as an explanation for the increased potas-
sium—mediated aldosterone responses in renal failure. Our
studies in metabolic clearance rates of aldosterone indicate that
there are no major changes in aldosterone metabolism in renal
failure that could account for these findings. It is possible,
however, that a mild, negative sodium balance in the renal
failure dogs as partially reflected in their weight loss could
contribute to the potentiation of K-induced aldosterone re-
sponses.
Insulin has been proposed as a major control system to
maintain internal potassium balance by inducing net—cellular
potassium uptake [7]. Potassium, in turn, can stimulate insulin
release as originally demonstrated in isolated pancreatic tissue
and from isolated islet—cell preparations [29—3 1]. Infusion of
large amounts of potassium in animals accompanied by large
increases in plasma potassium concentration can raise periph-
—
eral insulin levels [32—34] but smaller increments in potassium
have less effect on insulin release [35]. In man, potassium
loading is accompanied by small, but significant, increments in
serum insulin levels occurring within the physiologic range of
changes in serum potassium [27, 36].
The physiologic significance in renal failure of this potas-
sium—insulin interaction has been questioned including the role
of potassium—stimulated insulin release and the contribution of
insulin in enhancing cellular uptake of potassium [37]. In studies
of acutely nephrectomized dogs, potassium infusion increased
serum insulin levels, but the magnitude of the increase was
similar to control animals [33, 38]. Bourgoignie et al [27]
reported significantly higher basal serum insulin and glucagon
levels in remnant kidney dogs. In their studies, however, oral
challenge with 50 mEq of KCI in remnant dogs on a low (15
mEq) daily potassium intake did not significantly increase
insulin and glucagon levels. These findings contrast with our
results that show that both pre-infusion and potassium—stimu-
lated plasma insulin levels are significantly increased over
control in remnant kidney dogs. Our findings also show a
dependence of insulin responses on external potassium balance,
and that may account for the differences from the results of
Bourgoignie et al, who studied dogs on a low (15 mEq)
potassium intake. In the limited number of human studies,
intravenous potassium loading in anuric patients studied on a
regular potassium diet did not show major increments in serum
insulin levels post-infusion [221.
High insulin levels in renal failure dogs could be explained by
a reduced metabolism of insulin in renal failure. Studies by
DeFronzo et al [39] examining the metabolic clearance of
insulin predialysis noted lower clearance than in controls, but
the differences were not significant. Thus, it would seem
unlikely that the hyperinsulinemia observed in our remnant
dogs resulted from major changes in insulin metabolism. The
sympathetic nervous system may contribute to potassium—
induced insulin responses, as epinephrine added to KCI infu-
sions in renal failure dogs enhances insulin responses [40]. Our
study did not quantify changes in sympathetic nervous system
activity, so no conclusions can he made regarding this possibil-
ity.
Insulin may contribute to enhanced cellular uptake of potas-
sium as part of the increased extrarenal disposal of potassium in
renal failure. The blunted kaliuretic response to KC1 loading in
the remnant dogs accompanied by a normal plasma potassium
response suggest significant extrarenal disposal of the excess
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potassium. The temporal occurrence of these two events during
potassium challenge, hyperinsulinemia, and maintenance of
normal plasma potassium responses in the remnant dogs would
suggest that insulin is an important factor facilitating cellular
uptake of the excess potassium. In anephric dogs, Sterns [41]
found parallel oscillations in plasma potassium and insulin
during potassium infusion. Although the findings suggested a
control loop between potassium and insulin, inhibition of insu-
lin release with somatostatin or abolition by pancreatectomy
did not block plasma potassium responses implying that the
potassium control system can operate independently of insulin.
Early studies by Stems and coworkers [22] on potassium
disposal in anuric man also indicated a permissive rather than
regulatory action of endogenous insulin in cellular potassium
uptake. Pre-infusion and stimulated insulin levels were higher in
our studies than those reported by others, perhaps related to
higher dietary potassium intake and in part to the additional
effect of the acute oral load of KC1 during the pre-study feeding
preceding the infusion. These high levels of insulin, although
lowering blood glucose, did not produce hypoglycemia. Insulin
resistance for glucose uptake is common feature in renal failure
and could explain the high insulin levels and lack of hypogly-
cemia in our animals. There may also be significant differences
in the amount of insulin required to initiate cellular glucose
uptake compared to potassium uptake in renal failure. This is
compatible with forearm metabolism studies showing that lower
doses of insulin are required to produce changes in potassium
compared to changes in other insulin—dependent metabolic
functions [42, 43]. This differential sensitivity of insulin on
glucose and potassium is also seen in patients with insulin—
dependent diabetes mellitus and renal disease. Lack of insulin
in this setting will not produce hyperkalemia unless there are
additional deficiencies in the renin—aldosterone system [44—46].
Our results on the renal handling of potassium in dogs with
renal failure are in agreement with reports [46] showing a
blunted kaliuresis in renal failure and little effect of varying
dietary potassium intakes on UV in remnant dogs [27]. Our
findings expand on these observations by demonstrating that
even with very high potassium intake, there is a markedly
limited capacity of the remnant kidney to rapidly excrete an
acute potassium load. There was, however, an increase in
fractional excretion of potassium from the remnant kidney, and
it is possible that with the one to four hour delay in the action
of aldosterone on potassium excretion that the maximal excre-
tion of potassium was missed in our short—term studies.
The measurements of potassium distribution indicate a
marked increase in potassium transfer from the extracellular to
intracellular compartment in the renal failure dogs. This finding
offers the best explanation for the reason that, despite markedly
reduced renal potassium excretion in renal failure dogs, plasma
potassium increments after potassium loading were not dif-
ferent from controls. This pronounced effect on potassium
transfer in renal failure was not altered by external dietary
potassium balance, as the percentage transfer of potassium to
tissues was similar on low and high potassium intakes. The
temporal relationship between the high values of insulin and
aldosterone to the enhanced intracellular potassium uptake
suggests that these hormones participate in the extrarenal
distribution of potassium in renal failure. However, the higher
levels of aldosterone and especially insulin in the renal failure
dogs on the 200 mEq potassium diet did not further augment
tissue potassium uptake compared to the lower levels of these
hormones in dogs on 60 mEq intake. This finding could indicate
a threshold level beyond which insulin and aldosterone activate
tissue potassium uptake. A more sensitive analysis of this
process would have been direct tissue measurement of potas-
sium content, but this could not be performed in the present
study. The lower plasma bicarbonate values in renal failure
reflecting mild acidemia could cause movement of potassium
out of tissues and thus lead to underestimation of differences in
extrarenal potassium distribution between study groups. It is
doubtful, however, that the small differences in acid—base
balance between study groups accounts for the major differ-
ences in extrarenal potassium handling.
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